fda glp-1 compounding enforcement news october 2025 GLP-1s in 2026: What Brokers Need to Know GLP-1 News for 2026: New

This allows the body to adjust to the GLP-1 effects through a low dose that minimizes gastrointestinal side effects

For long term storage it is recommended to add a carrier protein (0.1%HSA or BSA)

In a meta-regression analysis of 18 CVOTs, including 8 with GLP-1RAs, a significant association between HbA1c reduction and major adverse cardiovascular events (including cardiovascular mortality, non-fatal myocardial infarction [MI], heart failure, and non-fatal stroke) was shown

Over time, your healthcare provider may increase the dosage based on your response to the medication, optimizing the effects

Earlier this summer , we shared our first peptide update after the FDA announced that its Pharmacy Compounding Advisory Committee, known as PCAC, would meet on July 23 and 24, 2026

Consider initial therapy at this stage when glycated hemoglobin (HbA1C) 9% ( 75 mmol/mol)